Matcha XXL | 76.47mg Per Tablet

Alkaloid Profile (Per Tablet)

Total Alkaloid Content: 76.47 mg

7-Hydroxymitragynine: 98.42% (75.26mg)

Mitragynine Pseudoindoxyl: 1.58% (1.21mg)

Packaging Information

Packaging: Green mylar

Single Pack: 5 tablets per pack

Multipack: 25 tablets per pack

Product Description

Matcha Milkshake is an ultra-high-strength tablet formulation engineered for experienced users who demand maximum potency, extended duration, and uncompromising consistency. This formulation sits firmly in the upper tier of the 7OHBLACK lineup and is intended only for those with established tolerance.

Driven by a very high concentration of 7-Hydroxymitragynine, Matcha Milkshake delivers intense physical relief and deep relaxation with a dense, sustained profile. A precise inclusion of Mitragynine Pseudoindoxyl and supporting trace alkaloids adds balance and structure, producing a full-spectrum experience that builds steadily and remains long-lasting.

Pressed tightly for durability and consistency, Matcha Milkshake is a Thai Style tab that prioritizes depth and endurance over immediacy. It is best suited for users managing significant discomfort or prolonged demands who require a powerful, reliable option and understand the importance of measured use.

Caution & Responsible Use

This product is not intended for beginners or casual users. Matcha Milkshake contains an extremely high total alkaloid concentration and should be approached with caution, even by experienced individuals. Start with a very small amount, allow ample time to fully assess effects, and do not redose prematurely. This is not a microdosing product—responsible, controlled use is essential.

This product is not available for shipment to the following states: Alabama, Arkansas, Indiana, Rhode Island, Wisconsin, Florida; or the following counties: San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Ohio, and Rapides (Louisiana).

FDA Disclaimer:

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.

Kratom products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, or as a treatment for any medical condition. The information provided on this website is for educational purposes only and should not be construed as medical advice. Kratom is not intended to diagnose, treat, cure, or prevent any disease.